CeriBell (NASDAQ:CBLL) reported fourth-quarter and full-year 2025 results that management said reflected continued ...

Delirium is a sudden onset of acute confusion in which those affected are disoriented, have impaired attention, and experience altered perception -often accompanied by hallucinations or sleep ...

CeriBell Inc (CBLL) reports significant revenue growth and market expansion, but faces hurdles with net losses and operational expenses.

Q4 2025 earnings call highlights: 34% revenue growth, $3.5B TAM, FDA milestones, and 2026 guidance of $111–$115M—read now.

There are an estimated 245,000 cases of life-threatening sepsis in the UK every year, claiming more lives than breast, bowel ...

Reported total revenue of $24.8 million in the fourth quarter of 2025, a 34% increase compared to the same period in 2024 Delivered total revenue of $89.1 million for the full year of 2025, a 36% ...

WhiteSands Alcohol & Drug Rehab Tampa has released a new educational resource focused on explaining “how inpatient alcohol rehabilitation programs are evaluated and selected within Florida’s treatment ...

You are a nurse practitioner in a nursing home. A staff member asks you to assess Mrs. B, a 90-year-old with mild dementia who is “not ...

A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/ .

Johnson & Johnson , a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug ...